You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson
Colorcon
McKinsey
Dow
Merck

Last Updated: August 7, 2020

DrugPatentWatch Database Preview

CEFTRIAXONE AND DEXTROSE IN DUPLEX CONTAINER Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Ceftriaxone And Dextrose In Duplex Container, and what generic alternatives are available?

Ceftriaxone And Dextrose In Duplex Container is a drug marketed by B Braun and is included in one NDA.

The generic ingredient in CEFTRIAXONE AND DEXTROSE IN DUPLEX CONTAINER is ceftriaxone sodium. There are twenty-six drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the ceftriaxone sodium profile page.

US ANDA Litigation and Generic Entry Outlook for Ceftriaxone And Dextrose In Duplex Container

A generic version of CEFTRIAXONE AND DEXTROSE IN DUPLEX CONTAINER was approved as ceftriaxone sodium by ASTRAL on January 20th, 2017.

  Start Trial

Summary for CEFTRIAXONE AND DEXTROSE IN DUPLEX CONTAINER
Drug patent expirations by year for CEFTRIAXONE AND DEXTROSE IN DUPLEX CONTAINER
Pharmacology for CEFTRIAXONE AND DEXTROSE IN DUPLEX CONTAINER

US Patents and Regulatory Information for CEFTRIAXONE AND DEXTROSE IN DUPLEX CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
B Braun CEFTRIAXONE AND DEXTROSE IN DUPLEX CONTAINER ceftriaxone sodium INJECTABLE;INJECTION 050796-001 Apr 20, 2005 AP RX Yes Yes   Start Trial   Start Trial   Start Trial
B Braun CEFTRIAXONE AND DEXTROSE IN DUPLEX CONTAINER ceftriaxone sodium INJECTABLE;INJECTION 050796-002 Apr 20, 2005 AP RX Yes Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Moodys
Dow
Express Scripts
Colorcon
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.